20
Cambrex Profarmaco Milano Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Cambrex is an innovative life sciences company with a refreshingly human approach.
One of their notable products is DIAZEPAM, with a corresponding US DMF Number 1478.
Remarkably, this DMF maintains an Active status since its submission on February 03, 1970, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 13, 2018, and payment made on June 20, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II